The Richardson Perspective

Children's Miracle Network launches a historic $1B pledge, with actor Adam Devine, to combat a deepening financial crisis in pediatric healthcare.

A new study shows the professional services market is slowing, but elite firms are widening the gap with a bold playbook of high investment and AI mastery.

Amid market pressures, VirTra showcases its advanced training simulators at SHOT Show, betting on immersive tech to redefine law enforcement training.

With a new lineup including a $699 model, ZWHAND's debut at CES 2026 could accelerate the mass adoption of dexterous robots in every field.

A massive loan package from CIM Group highlights its strategic pivot to hospitality and the unstoppable investor appeal of the resilient extended-stay hotel market.

The wellness firm secured a cash infusion by repricing options, a move that provides vital funds for its Zola brand but raises questions about dilution.

Following a successful three-year transformation, B-FLEXION acquires full ownership of Radius Health, betting big on its blockbuster osteoporosis drug TYMLOS®.

For the 24th straight year, nurses top Gallup's ethics poll, but this enduring trust masks a profession in crisis, battling burnout and staff shortages.

Uniper secures 500,000 tons of certified green ammonia from India's AM Green, forging a new energy axis and fueling Europe's industrial decarbonization.

A 2.9 MEUR deal for GomSpace to design lunar spacecraft for a major North American firm signals a new era for small satellites in deep space exploration.

The merger creates a data and AI powerhouse focused on the Snowflake ecosystem, aiming to help enterprises scale artificial intelligence responsibly.

Paris-based Enodia Therapeutics lands €20.7M to advance its AI platform that degrades disease-causing proteins at the point of synthesis, targeting new cures.

Frontier Airlines appoints decade-long veteran James Dempsey as its new CEO and raises its Q4 earnings outlook, signaling operational resilience.

How a blend of private capital and pragmatic regulation is turning Singapore into a global hub for longevity research, pushing scientific and ethical boundaries.

After success in Europe, Allotex gets FDA nod to begin U.S. trials for its tissue-based presbyopia treatment, offering new hope for millions.

Biotech leader Arrowhead Pharmaceuticals prices upsized offerings, signaling strong investor confidence and fueling its next wave of RNAi therapies.

With a robotic arm that lifts it from the water to charge itself, the new SPINO S1 Pro from MAMMOTION promises a truly autonomous pool care future.

At CES 2026, Agibot launched its open-source platform that uses real-world data and LLMs to train robots, aiming to set a new industry standard.

A groundbreaking Duke trial combines a novel device to lure cancer cells with targeted immunotherapy, offering real-time tracking and new hope for patients.

An Indianapolis firm's major investment boosts domestic battery manufacturing, aiming to secure the supply chain for critical military and drone technology.